| Literature DB >> 35599865 |
Minjeong Kang1,2,3, Keunsub Lee1,2, Todd Finley4, Hal Chappell4, Veena Veena4, Kan Wang1,2.
Abstract
For maize genome-editing and bioengineering, genetic transformation of inbred genotypes is most desired due to the uniformity of genetic background in their progenies. However, most maize inbred lines are recalcitrant to tissue culture and transformation. A public, transformable maize inbred B104 has been widely used for genome editing in recent years. This is primarily due to its high degree of genetic similarity shared with B73, an inbred of the reference genome and parent of many breeding populations. Conventional B104 maize transformation protocol requires 16-22 weeks to produce rooted transgenic plants with an average of 4% transformation frequency (number of T0 plants per 100 infected embryos). In this Method paper, we describe an advanced B104 transformation protocol that requires only 7-10 weeks to generate transgenic plants with an average of 6.4% transformation frequency. Over 66% of transgenic plants carried CRISPR/Cas9-induced indel mutations on the target gene, demonstrating that this protocol can be used for genome editing applications. Following the detailed and stepwise procedure described here, this quick and simplified method using the Agrobacterium ternary vector system consisting of a T-DNA binary vector and a compatible helper plasmid can be readily transferable to interested researchers.Entities:
Keywords: CRISPR-Cas9; Zea mays; bialaphos; helper plasmid; tissue culture
Year: 2022 PMID: 35599865 PMCID: PMC9114882 DOI: 10.3389/fpls.2022.860971
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
FIGURE 1Schematic illustration of the ternary vector system used for maize B104 transformation. (A) Binary construct pKL2013 (McCaw et al., 2021), 17,777 bp. PZmUbi, maize polyubiquitin gene promoter; zCas9, maize codon-optimized Cas9 from Streptococcus pyogenes; TrbcS-E9, transcriptional terminator from Pisum sativum rbcS-E9 gene; POsU3, a promoter from Oryza sativa U3 small nucleolar RNA (snoRNA) gene; ZmGl2-sgRNA1, single-guide RNA targeting maize glossy2 gene (Lee et al., 2019); TOsU6-2, terminator from O. sativa OsU6-2 snoRNA gene; Tvsp, terminator from soybean vegetative storage protein gene; mCherry, red fluorescent protein; P35S, CaMV 35S promoter; bar, bialaphos resistance gene; RB, the T-DNA right border repeat; LB, the T-DNA left border repeat; KanR, kanamycin resistance gene cassette; pBR322 ori, high copy number origin of replication for E. coli; pVS1 ori, the origin of replication from the plasmid pVS1. (B) Ternary construct or helper plasmid pKL2299 (this work), 29,605 bp. virB1-virJ, virulence genes from the Agrobacterium tumefaciens Bo542 tumor-inducing plasmid (pTiBo542); RK2 ori, the origin of replication from the broad host range RK2 plasmid; GmR, gentamicin resistance gene cassette.
Stock solutions and preparations.*
| Item | Stock | Stock solution concentration | Quantity | Dissolve in | Preparation note | Storage temp (°C) | Storage days |
| 1 | 2,4-Dichlorophenoxyacetic acid (2,4-D) | 0.5 mg/mL | 50 mg | 10 mL 1 N NaOH + 90 mL H2O | Dissolve 2,4-D in 10 mL 1 M NaOH, then bring the volume to 100 mL with ddH2O. | 4 | 60 |
| 2 | 6-Benzylaminopurine (BAP) | 1 mg/mL | 100 mg | 10 mL 1 N NaOH + 90 mL H2O | Dissolve BAP in 10 mL 1 M NaOH, then bring the volume to 100 mL with ddH2O. | 4 | 60 |
| 3 | AB buffer (20X) | 20X | See Note | dH2O, 1 L | 60 g/L K2HPO4, 20 g/L NaH2PO4 | 4 | 60 |
| 4 | AB salts (20X) | 20X | See Note | dH2O, 1 L | 20 g/L NH4Cl, 6 g/L MgSO4⋅7H2O, 3 g/L KCl, 0.228 g/L CaCl2⋅2H2O | 4 | 60 |
| 5 | Abscisic acid (ABA) | 0.1 mg/mL | 1 mg | 1 mL 1 N NaOH + 9 mL H2O | −20 | 90 | |
| 6 | Acetosyringone (AS) | 100 mM | 196.2 mg | DMSO, 10 mL | Make 10 mL stock and aliquote for single use | −20 | 90 |
| 7 | B5H minor salts | 1000X | See Note | dH2O, 1 L | 3 g/L H3BO3, 10 g/L MnSO4⋅H2O, 0.25 g/L Na2MoO4⋅2H2O, 0.75 g/L KI | Room temp | 60 |
| 8 | Bialaphos | 2 mg/mL | 20 mg | dH2O, 10 mL | −20 | 60 | |
| 9 | Carbenicilline | 100 mg/mL | 1 g | dH2O, 10 mL | −20 | 90 | |
| 10 | Cupric sulfate | 1 mg/mL | 100 mg | dH2O, 100 mL | Make 100 mL stock | 4 | 1000 |
| 11 | Dicamba | 1 mg/mL | 10 mg | 0.5 mL EtOH + 9.5 mL ddH2O | Dissolve Dicamba in 5 mL 100% EtOH, then bring the volume to 10 mL with ddH2O. Media containing Dicamba should store in dark. | 4 | 120 |
| 12 | Eriksson’s vitamins | 1000X | See Note | dH2O, 100 mL | 2 g/L glycine, 0.5 g/L nicotinic acid, 0.5 g/L pyridoxine⋅HCL, 0.5 g/L thiamine⋅HCL (or Phytotech E330) | 4 | 90 |
| 13 | FeSO4⋅7H2O | 1.25 mg/mL | 125 mg | dH2O, 100 mL | 25 | 90 | |
| 14 | Gentamincin | 50 mg/mL | 5 g | dH2O, 100 mL | −20 | 90 | |
| 15 | Kanamycin | 50 mg/mL | 5 g | dH2O, 100 mL | −20 | 90 | |
| 16 | N6 Macronutrient stock (10X) | (for 60 mL/L) | See Note | dH2O, 1 L | 1.66 g/L CaCl2⋅2H2O, 4.62 g/L (NH4)2SO4, 4 g/L KH2PO4, 1.85 g/L MgSO4⋅7H2O, 28.3 g/L KNO3 | 4 | 90 |
| 17 | NaFe EDTA for B5H (100X) | (for 6 mL/L) | See Note | dH2O, 100 mL | 3.7 g/L EDTA-Na2⋅H2O, 2.79 g/L FeSO4⋅7H2O | 4 | 60 |
| 18 | Nicotinic acid | 1 mg/mL | 100 mg | dH2O, 100 mL | 4 | 120 | |
| 19 | Pyridoxine⋅HCl | 1 mg/mL | 100 mg | dH2O, 100 mL | 4 | 120 | |
| 20 | Schenk and Hildebrandt Vitamin | 100X | See Note | dH2O, 100 mL | 100 g/L myo-inositol, 0.5 g/L nicotinic acid, 0.05 g/L pyridoxine⋅HCl, 0.5 g/L thiamine⋅HCl (or Phytotech, S826) | 4 | 90 |
| 21 | Silver Nitrate | 2 mg/mL | 200 mg | 100 mL | Store in dark. Media containing silver nitrate should be stored in dark. | 4 | 90 |
| 22 | Spectinomycin | 50 mg/mL | 5 g | dH2O, 100 mL | If the stock is crystalized, rethaw and redissolve at 37°C before use. | −20 | 90 |
| 23 | Thiamine⋅HCl | 1 mg/mL | 100 mg | 100 mL | Cover with aluminum foil and keep in dark. | 4 | 60 |
| 24 | Thidiazuron (TDZ) | 0.1 mg/mL | 1 mg | 1 mL 1 N NaOH + 9 mL H2O | 4 | 90 | |
| 25 | Thymidine | 25 mg/mL | 250 mg | dH2O, 10 mL | If the stock is crystalized, rethaw and redisolve at 37°C before use. | 4 | 90 |
| 26 | Zeatin, trans | 0.5 mg/mL | 50 mg | 5 mL 1 N NaOH + 95 ml ddH2O | Dissolve | 4 | 60 |
*All stock solutions should be filter sterilized using 0.22 μM syringer filter or Stericup filtration system, except for item 6. Items 3 and 4 can also be sterilzed by autoclave.
Media for B104 transformation (modified from Hoerster et al., 2020).
| Name | Chemical | Final conc. | Vendor/Cat info |
| Mother plate | glucose | 5 g/L | Fisher scientific, D16 |
| AB buffer | Bacto agar | 15 g/L | BD Biosciences, 214030 |
|
| |||
| AB buffer (20X) | 1X | ||
| AB salts (20X) | 1X | ||
| FeSO4⋅7H2O (1.25 mg/mL) | 2.5 mg/L | Fisher scientific, I146 | |
| thymidine (25 mg/mL) | 50 mg/L | Millipore Sigma, T1895 | |
| gentamicin (50 mg/mL) | 50 mg/L | Phytotech labs, G570 | |
| and/or | kanamycin (50 mg/mL) | 50 mg/L | Millipore Sigma, K1377 |
| and/or | spectinomycin (100 mg/mL) | 100 mg/L | Millipore Sigma, S4014 |
|
| |||
| Working plate | sodium chloride | 5 g/L | Fisher scientific, S271 |
| YEP base | yeast extract | 5 g/L | Fisher scientific, BP14222 |
| pH 6.8 | peptone | 10 g/L | BD Biosciences, 211677 |
|
| |||
| Bacto agar | 15 g/L | BD Biosciences, 214030 | |
|
| |||
| thymidine (25 mg/mL) | 50 mg/L | Millipore Sigma, T1895 | |
| gentamicin (50 mg/mL) | 50 mg/L | Phytotech labs, G810 | |
| and/or | kanamycin (50 mg/mL) | 50 mg/L | Millipore Sigma, K1377 |
| and/or | spectinomycin (100 mg/mL) | 100 mg/L | Millipore Sigma, S4014 |
|
| |||
| Infection | MS basal salt mixture | 4.33 g/L | MilliporeSigma, M5524 |
| 700A | myo-inositol | 0.1 g/L | MilliporeSigma, I3011 |
| pH 5.2 | nicotinic acid (1 mg/mL) | 0.5 mg/L | MilliporeSigma, N0761 |
| pyridoxine⋅HCl (1 mg/mL) | 0.5 mg/L | MilliporeSigma, P8666 | |
| thiamine (1 mg/mL) | 10 mg/L | MP biomedicals, 194749 | |
| casamino acids | 1 g/L | Fisher scientific, BP1424 | |
| sucrose | 68.5 g/L | Fisher scientific, BP220 | |
| glucose | 36 g/L | Fisher scientific, D16 | |
| 2,4-Dichlorophenoxyacetic acid (2,4-D) (0.5 mg/mL) | 1.5 mg/L | MilliporeSigma, D7299 | |
|
| |||
|
| |||
| Add thymidine (25 mg/mL) | 50 mg/L | Millipore Sigma, T1895 | |
| Add acetosyringone (AS) (100 mM) | 100 μM | Millipore Sigma, D134406 | |
|
| |||
| Co-cultivation | MS basal salt mixture | 4.33 g/L | MilliporeSigma, M5524 |
| 710I | myo-inositol | 0.1 g/L | MilliporeSigma, I3011 |
| pH 5.6 | nicotinic acid (1 mg/mL) | 0.5 mg/L | MilliporeSigma, N0761 |
| pyridoxine⋅HCl (1 mg/mL) | 0.5 mg/L | MilliporeSigma, P8666 | |
| thiamine (1 mg/mL) | 10 mg/L | MP biomedicals, 194749 | |
| proline | 0.7 g/L | Alfa Aesar, A10199 | |
| sucrose | 20 g/L | Fisher scientific, BP220 | |
| glucose | 10 g/L | Fisher scientific, D16 | |
| 2-( | 0.5 g/L | Fisher scientific, BP300 | |
| 2,4-D (0.5 mg/mL) | 2 mg/L | MilliporeSigma, D7299 | |
|
| |||
| agar | 8 g/L | MilliporeSigma, A7921 | |
|
| |||
| acetosyringone (AS) (100 mM) | 100 μM | Millipore Sigma, D134406 | |
| thymidine (25 mg/mL) | 50 mg/L | Millipore Sigma, T1895 | |
| silver nitrate (2 mg/mL) | 1 mg/L | Fisher scientific, S181 | |
|
| |||
| Resting | MS basal salt mixture | 4.33 g/L | Phytotech labs, M5605 (11 g/L) |
| 605G | N6 macronutrient stock (10X) | 0.6X | Phytotech labs, M5605 (11 g/L) |
| pH 5.6 | B5H Minor salts (1000X) | 0.6X | Phytotech labs, M5605 (11 g/L) |
| NaFe EDTA for B5H (100X) | 0.6X | Phytotech labs, M5605 (11 g/L) | |
| Eriksson’s vitamins (1000X) | 0.4X | Phytotech labs, M5605 (11 g/L) | |
| Schenk and Hildebrandt vitamins (100X) | 0.6X | Phytotech labs, M5605 (11 g/L) | |
| potassium nitrate | 1.68 g/L | Phytotech labs, M5605 (11 g/L) | |
| thiamine HCl (1 mg/mL) | 0.2 mg/L | Phytotech labs, M5605 (11 g/L) | |
| proline | 2 g/L | Phytotech labs, M5605 (11 g/L) | |
| sucrose | 20 g/L | Fisher scientific, BP220 | |
| glucose | 0.6 g/L | Fisher scientific, D16 | |
| casein hydrolysate | 0.3 g/L | Thermo fisher scientific, J12855-P2 | |
| 2,4-D (0.5 mg/mL) | 0.8 mg/L | MilliporeSigma, D7299 | |
|
| |||
| TC agar | 6 g/L | Phytotech labs, A296 | |
|
| |||
| dicamba (1 mg/mL) | 1.2 mg/L | Phytotech labs, D159 | |
| silver nitrate (2 mg/mL) | 3.4 mg/L | Fisher scientific, S181 | |
| carbenicilline (100 mg/mL) | 100 mg/L | Phytotech labs, C346 | |
|
| |||
| Maturation | MS basal salt mixture | 4.33 g/L | MilliporeSigma, M5524 |
| 13329B | cupric sulfate (1 mg/mL) | 1.25 mg/L | MilliporeSigma, C2857 |
| pH 5.6 | myo-inositol | 1 g/L | MilliporeSigma, I3011 |
| proline | 0.7 g/L | Alfa Aesar, A10199 | |
| sucrose | 60 g/L | Fisher scientific, BP220 | |
| zeatin, | 0.5 mg/L | Phytotech labs, Z125 | |
|
| |||
| agar | 7 g/L | MilliporeSigma, A7921 | |
|
| |||
| abscisic acid (ABA) (0.1 mg/mL) | 0.1 mg/L | MilliporeSigma, 862169 | |
| 6-Benzylaminopurine (BAP) (1 mg/mL) | 1 mg/L | MilliporeSigma, B3408 | |
| thidiazuron (TDZ) (0.1 mg/mL) | 0.1 mg/L | Phytotech labs, T888 | |
| carbenicilline (100 mg/mL) | 100 mg/L | Phytotech labs, C346 | |
| 11329B3 | bialaphos (2 mg/mL) | 3 mg/L | Gold Biotechnology, B0178 |
| 11329B6 | bialaphos (2 mg/mL) | 6 mg/L | Gold Biotechnology, B0178 |
|
| |||
| Rooting | MS basal salt mixture | 4.33 g/L | MilliporeSigma, M5524 |
| 13158B2 | myo-inositol | 0.1 g/L | MilliporeSigma, I3011 |
| pH 5.6 | sucrose | 40 g/L | Fisher scientific, BP220 |
|
| |||
| Bacto agar | 7 g/L | BD Biosciences, 214030 | |
|
| |||
| bialaphos (2 mg/mL) | 2 mg/L | Gold Biotechnology, B0178 | |
*See
FIGURE 2Growing maize donor plants for immature embryo production. (A) Standard flat with small pots filled with potting mix for planting maize seed. (B) Six-day-old germinated seedlings under a humi-dome. (C) Two-week-old seedlings ready to be transplanted into large pots. (D) A seedling transplanted to a large pot. (E) Plants on a 1 m tall bench. (F) Pollinated mature B104 plants on the floor. (G) An un-pollinated B104 ear (female flower) with emerged silks. (H) A shoot bag covering an un-pollinated B104 ear. (I) A mature tassel (male flower) ready to be used for pollination. (J) A pollination bag covering a mature tassel for the purpose of collecting fresh pollen. (K) An un-pollinated B104 ear with cut silks. (L) Freshly collected pollen in a tassel bag. (M) Freshly pollinated silks, 1 day after silks were cut. (N) Extracting an immature embryo for measurement while the ear is still growing on the plant. (O) Measurement of an embryo size with a caliper. (P) Estimate of an embryo size with a ruler.
FIGURE 3Embryo dissection, infection, and co-cultivation. An Agrobacterium “mother” plate (A) and “working” plate after 18 h incubation, streaked by a disposable loop (B). (C) A B104 ear halves on a handle made of a fork. (D) Tools for embryo dissection; a micro spatula (left) and a dental filling instrument (right). (E) A co-cultivation plate with dissected immature embryos. All embryos were re-oriented scutellum side up. (F) A plastic culture box filled with plates. (G) Cartoon illustration of the embryo dissection and infection process. Step 1, remove kernel tops using a sterile scalpel; Step 2, isolate embryo from the kernel and transfer it to a tube filled with liquid 700A infection medium; Step 3, after infection, place embryo onto co-cultivation medium and orient the embryos by placing them scutellum side up. e: embryo, s: endosperm, and p: pericarp. Demonstration of embryo dissection using a micro spatula (H) or a dental filler (I). The arrows indicate the embryo side of the kernel. Circles highlight isolated embryos.
FIGURE 4Regenerated T0 plantlets from rooting stage to acclimatization in soil. (A) Plantlets growing on the rooting medium. Sundae cup is used as a cover to give vertical space to grow. (B) Regenerated plantlets ready to be moved to potting mix. Red arrows indicate plantlets with healthy roots. (C) Plantlet representing bushy phenotype or multiple shoot cluster. (D) Single-shoot plantlet ready to be transplanted to potting mix. (E) T0 regenerated plantlets transplanted to potting mix. (F) A plant propagation tray covered with a humi-dome to aid in acclimatization.
Summary of transformation frequency (TF) of three experiments.
| EXP | Nr. of ears | Nr. of infected Embryos | Nr. of regenerants | % regenerants | Nr. of T0 event | % TF |
| ALT1-CAS | 3 | 110 | 38 | 34.5% | 10 | 9.1% |
| ALT2-CAS | 5 | 111 | 11 | 9.9% | 2 | 1.8% |
| ALT3-CAS | 3 | 142 | 23 | 16.2% | 12 | 8.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FIGURE 5Transient and stable transformation. Observation of transient RFP expression 3 days post-infection on the middle of the scutellum (A) or the side of the embryos (B). (C) Somatic embryogenesis on embryo scutellum side, 8 days post-infection in bright field. Observation of stable transformation and callus formation of maize embryo under bright field (D) and RFP field overlayed (E). The arrows indicate callus with the RFP expression. (F) Tentacle-like structure on a callus during the maturation stage, 21 days post-infection. Maize callus on the maturation I medium, 18 days post-infection (G) and the maturation II medium, 31 days post-infection (H).
Comparison of conventional and improved B104 transformation methods.
| Step | Activities | Day of Action | |
| Conventional | Improved | ||
| 1 | Agro strain preparation | Day 0 | Day 0 |
| 2 | Embryo dissection, infection, co-cultivation | Day 1 | Day 1 |
| 3 | Resting | N/A | Day 2 |
| 4 | Shoot formation and selection I | Day 4 | Day 9 |
| 5 | Shoot formation and selection II | Day 18 | Day 19 |
| 6 | Bulking | Day 60 | N/A |
| 7 | Regeneration and selection | Day 137 | N/A |
| 8 | Rooting | Day 151 | Day 33 |
| 9 | Moving to soil | Day 165 | Day 51 |
FIGURE 6Phenotypes of T0 transgenic plants. Observation of mature shoots with roots on the maturation II medium under an RFP channel (A) and a bright field (B). Black arrow indicates a shoot with RFP expression; white arrow indicates a shoot without RFP expression. Observation of the gl2 knock-out phenotype on a T0 regenerated plant (C) and a wild-type seedling after water spray (D). Observations of pollen grains collected from a T0 plant (E,F) and a wild-type B104 control (G,H). Images of (E,G), bright field; (F,H), RFP field overlay.
Summary of T0 mutant genotypes.*
| Number of plants | % T0 mutant | |
| Homozygous | 1 | 4.2% |
| Biallelic | 7 | 29.2% |
| Heterozygous | 2 | 8.3% |
| Mosaic | 6 | 25.0% |
| Wild type | 8 | 33.3% |
|
|
|
|
*Homozygous, one mutant sequence without wild type allele; Biallelic, two different mutant sequences; Heterozygous, wild type sequence and one mutant sequence; Mosaic, three or more mutant sequences in a single plant.
FIGURE 7Phenotypes and genotypes of sixteen T0 mutant events. Plant ID shows experiment ID, embryo ID, and plantlet ID (EXP-embryo-plantlet). Three gl2 phenotypes: gl2, glossy mutant phenotype; gl2/wt mixed, both glossy mutant and wild type phenotype on the same leaf; wt, wild-type phenotype. Red letters, target sequences in Gl2 exon2; Blue letters, PAM sequences; Black letter, insertion mutations; dashed lines, deletions. T0 gl2 phenotyping is considered a preliminary screening assay.